NRIXNurix Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · nurixtx.com

26.72USD-3.85%Mkt Cap: 2.77B $P/E: —3d ago

Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and antibody therapies for the treatment of cancer, inflammatory condit…

Headline	Source	Time
Older
Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says Nurix Therapeutics' (NRIX) STAT6 degrader NX-3911 is likely to receive increased recognition after a	MMT Newswires	Aug 10
Nurix Therapeutics (NRIX) Lands $10 Million Milestone As Phase 3 Trial Begins Nurix Therapeutics (NasdaqGM:NRIX) announced a $10 million milestone payment tied to the first in human trial of an oral STAT6 degrader in its collaboration with Sanofi. The company also reported enrollment of the first patient in a pivotal global Phase 3 trial of bexobrutideg for relapsed or refractory chronic lymphocytic leukemia in partnership with Roche. Both programs advance Nurix's clinical pipeline in targeted protein degradation and expand its work with large pharmaceutical...	Simply Wall St.	Aug 5
Is Kymera Therapeutics Poised for a Breakthrough With KT-621? Kymera Therapeutics advances KT-621 enrollment ahead of schedule, bringing pivotal atopic dermatitis data closer as it expands its protein degrader pipeline.	Zacks	Jul 24
Company News for July 13, 2026 Companies In The Article Are:WDFC,DAL,NRIX and FCX	Zacks	Jul 13
Nurix Therapeutics, Inc. (NRIX) Reports Q2 Loss, Lags Revenue Estimates	Zacks	Jul 9
Earnings Preview: Nurix Therapeutics, Inc. (NRIX) Q2 Earnings Expected to Decline	Zacks	Jul 1
Wall Street Analysts Believe Nurix Therapeutics (NRIX) Could Rally 29.23%: Here's is How to Trade	Zacks	Jul 1
Nurix Therapeutics, Inc. (NRIX) Price Target Raised to $33 on Roche Partnership Value	IInsider Monkey	Jun 30
Nurix Therapeutics (NRIX) Soars 16.4%: Is Further Upside Left in the Stock?	Zacks	Jun 26
Nurix (NRIX) Climbs to 52-Week High — This Deal May Hold the Answer	IInsider Monkey	Jun 26
Nurix Therapeutics (NRIX) Stock Looks Expensive Even With A $31 Analyst Target	Simply Wall St.	Jun 16
Truist is Bullish on Nurix Therapeutics, Inc. (NRIX)	IInsider Monkey	Jun 16
Canopy Growth Corporation (CGC) Reports Q4 Loss, Lags Revenue Estimates	Zacks	Jun 15
TG Therapeutics (TGTX) Soars 7.5%: Is Further Upside Left in the Stock?	Zacks	Jun 11
Strength Seen in Nurix Therapeutics (NRIX): Can Its 6.8% Jump Turn into More Strength?	Zacks	Jun 9
Company News for Jun 9, 2026	Zacks	Jun 9
Broader Market Settles Higher as Chipmakers Rally	Barchart	Jun 8
Roche Inks $2.3 Billion Deal, Sending This Small Biotech Stock Flying	Investor's Business Daily	Jun 8
Roche's $2.3 Billion Nurix Deal Sends Shares Moving	GuruFocus.com	Jun 8
Roche Licenses Nurix Therapeutics Blood-Cancer Drug for Up to $2.3 Billion	The Wall Street Journal	Jun 8
Stocks Rally as Buyers Return After AI-Led Selloff	Barchart	Jun 8
This Biotech Stock Is Popping 10% on $2.3 Billion Roche Deal for Blood Cancer Drug	Barrons.com	Jun 8
Stocks Push Higher as Chipmakers and AI Companies Rebound	Barchart	Jun 8
Roche stakes $700M on Nurix’s protein-degrading drug	BioPharma Dive	Jun 8
Roche and Nurix strike $2.3 billion blood cancer drug deal	Quartz	Jun 8
Roche signs $2.3bn blood cancer drug agreement with Nurix Therapeutics	Pharmaceutical Technology	Jun 8

NRIXNurix Therapeutics, Inc.

Industry Peers